CD8+ tumor-infiltrating lymphocytes (TIL) [4, 6] and tumor cell PD-L1 expression [7] have been associated with improved patient survival, indicating that the immune system is able to exert some control over this aggressive neoplasm. The gene discussed is CD8A; the disease is neoplasm.